Engineered Bacillus subtilis for the de novo production of 2′-fucosyllactose

Quanwei Zhang,Zhenmin Liu,Hongzhi Xia,Ziyang Huang,Yonglian Zhu,Linfeng Xu,Yanfeng Liu,Jianghua Li,Guocheng Du,Xueqin Lv,Long Liu
DOI: https://doi.org/10.1186/s12934-022-01838-w
IF: 6.352
2022-06-03
Microbial Cell Factories
Abstract:The most abundant human milk oligosaccharide in breast milk, 2′-fucosyllactose (2′-FL), has been approved as an additive to infant formula due to its multifarious nutraceutical and pharmaceutical functions in promoting neonate health. However, the low efficiency of de novo synthesis limits the cost-efficient bioproduction of 2′-FL.
biotechnology & applied microbiology
What problem does this paper attempt to address?